Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Naw, what I have no use for is folks who aren't smart enough to want to know the TRUTH...
and don't have the internal character traits to make sure they aren't being lied to..
Naw, what I have no use for is folks who aren't smart enough to want to know the TRUTH...
You mean to tell me YOU aren't aware that Jan 6th WAS a fed gov't set up??
And that the J6 so called 'committee' IS GUILTY of destroying evidence, that they are LIARS
and should be jailed for what they 'ran'??
Mercy.. talk about UNINFORMED..
Thats amusing. I have found that getting folks to talk, exposes their true character.
and as I suspect with you based on your comment already, you are less than you believe yourself to 'be'. (smile)
Its the stock market, things go up and down all the time, even when a 'run' is happening..
Should stay focused on the CHART. Cause at the moment, the share price is looking for its Moving Average line.
The share price has gotten ahead of this MA line, and from experience, they don't like to get separated for too long
before they want to get back together again. This happens over and over again..
Now I have to figure out how to post a snapshot of my chart on this forum.. to show you what I mean. Hmmm
Its why its said, liberals/commies/democrats really 'care' about you until someone elses money runs out..
Or you are no longer a useful idiot to for their agenda...
Magatards want Civil War huh ,,,
Do YOU understand CAUSE and EFFECT??
agree...
On the R/split: doing one right now would get the share price up to a $, but no where close to the $5/ range the institutionals like to be buyers at.
and to do one now, at least a 1-10 and that would leave around 30 Mil shares.. would be nice going forward..
So IF it gets to 50 cents (or a $)? I would not be surprised to see them do a 1-10 (1-5) to cut the share count down to around 30 (60) Mil, bump the share price up to $5 and get the institutionals buying which of course is what is really needed to push the share price up.
Going to be a challenge for the retailers alone to pull it up to 50 cents if it remains under pressure by short sellers.
It will reverse IF/WHEN management provides the catalyst. Until then, if you believe?
Have a cup of coffee and laugh at the efforts of those like petey..
Going to need DETAILS from management
A PR update on what this licensing 'means' to them in terms of possible revenue, WHEN its likely to commence, et al.
Market has been running on 'FUMES' for quite a while now and folks are looking for something undervalued relative to its potential.
Just needs a catalyst to draw their attention to it with an outlook that gives them a timeframe to work on.
Disclaimer: like the potential, what happens in the meantime is 'noise'.. and as is oft the case, get a lot of useless posters
showing up to show their ignorance or have their fun while they can (smile)
that's how you make money? is it not?
Yes, the really big money tends to be made by those patient enough to let the company move forward.
Course, it also involves getting in 'early', and the company having a gameplan that the odds favor being 'achievable'..
To close, agree fully with this statement, primarily because I had a couple of 'good ones' that I got out of due to stumbles
on their part, and failure on mine to keep paying attention and getting back in...
As of today $JAGX close to 200M shares shorted share volum
??? They were ID'd as having 20 Mil shorted as of 3/28?? They have a 'total/implied' float of 321 Mil..
You are saying that 2/3rds of the shares are now shorted?? Care to share the source?? Just for info. Thanks
Have to expect a r/split somewhere down the road. Guessing management is hoping to see the share price lifted before they
decide to do one. Cause its no secret, the bigger players (institutionals) don't like to play with shares (used to be $7, now appears to be $5)
don't like to buy really cheap shares.
And the 'retail' sector is going to have a tough time lifting this all the way to $5 by themselves unless they announce 'earnings' have commenced. Not sure they can get 'there' before Aug..
Thinking 50 cents to a $ would be a heavy lift as it is. As I suspect a r/split will happen to kill off the large share count to something a lot more 'reasonable' (300 Million to say 50 Million??) to get to $5? Be nice to see a $ first..
When you have the VOLUME traded like they are seeing? Have to believe there is some 'flipping' of shares for a few thousand in gains at a time.. (200000 shares cost $36000, goes up 2-3 cents?? Skim off a few thousand in gains at a time??)
Between this announcement and maybe a potentially 'acceptable' PH 3??
Could u/stand why management deferred on the r/split (for the moment) with respect to the
de-listing concern (and the Aug extension).
Licensing terms will be interesting to see, not to mention see what management
says with respect to the 'need' for this product.. (in terms of potential revenues and
any competition)
Disclaimer: own shares, and the more I 'learn' about them, the more I like the odds of
seeing 50 cents +..
Ok, but how 'good' a reason 'could' it be??
Agree, I grabbed some shares at .111 earlier in the week as a 'momentum' trade.
Intrigued that they pulled the r/split and apparently believe they can get to the $ share price to
meet the listing requirement.
Wondering what they 'see' in terms of POTENTIAL sales/revenues. Especially since even if the PH 3 is 'good', they are still looking at maybe 9 months at the least
for the fda to 'act'.. and that pushes any new sales past August..
one thing that can be said is, while it looks like it has 'bottomed' out.. can it give the market a reason to want shares again..
Time for a 'pause'?? Be happy if it could hold over $6+ while its Moving Average line which got 'lost' catches up..
Gets too far apart and its interesting to see how the share price and MA line seem to want to get back together. And unfortunately, it usually involves the share price being dragged lower..
Disclaimer: finally getting the move we have been looking for. 1st target price: $14 (hemo sector), 2nd target price: $25 (IF they can get the oncology sector)
Whats a CONSERVATIVE market cap??
231 Mil shares outstanding, current market cap $29 Million...
gets to 50 cents: 5x: $150 Million - is this 'justifiable' IF this product passes the PH 3?
a $?? 10x?? $230 Million?? is this 'justifiable'
Note: not saying these aren't possible as folks are more than willing to overpay to 'get some'.. but...
Anyone have any idea on the potential revenue expectations??
Disclaimer: own some just for the phase 3 trial update, be happy to see it hit 20-25 cents. And acknowledge its possible for the market to run it up to say 50 cents IF the news is positive as the market is looking for anything that can be called 'undervalued'.. But beyond that?? A full $ to get away from the de-listing??
Back in with the first buy in a long time... Still have a target price of $25.. Ticked that CRMD has taken so long to get going cause it made me miss one heck of a buying opp on ATNM sub $5...
Now to start selling covered calls and see if I can keep the shares..
Good luck..
Its all about MARKET CAP vs potential revenues.
Some of us who have been in this for a long time had a market cap of around $600 Million based on 'conservative' guesses for sales/pricing.
Gave me a target price of around $25-30 or so BEFORE the 1-5 r/split, with only 25 Mil or so shares outstanding post the 1-5. But now thanks to the dilution to raise cash, a share count of around 58 Million? Now my target price is down to around $14..
So while a 1-5 r/split has occurred, dilution that doubled the number of outstanding shares took place, the MARKET CAP that we 'guessed' at way back around 2016-2017 hasn't changed, won't change until the company/anal-ysts shed some more light on how things are going, and the anal-ysts update their revenue/profits and market cap 'expectations'..
So yeah, it has room to 'run' to the target price, thanks to the 2 frigging CRLS, the damage done has been to the target price expectations thanks to the dilution..
Good luck..
Been quite a while since I last owned shares (back in the 2017/18 timeframe). Been monitoring the developments from a big picture standpoint.
So after seeing the excitement over the Bascom PI activity, wondering if you have seen anyone project a 'timeline' on where things are vs when they might get to the end of a viable PH 3 for 'anything'..
Again, I am just ramping up my research into their status on their trials, et al.
Own no shares, but thinking committing $5000 at 20 cents or less would be a good idea.
Thanks
disclaimer: biggest position is in CRMD which is around $4, has recently been approved by the FDA and has a 'conservative' target price of $14. Sales are expected to commence before 1 July. Not a sexy development that attracts the market, but a NEEDED development. With a potential target price once they get approved for an even bigger sector of the market they could serve of around $25+ some... Yep, the potential for a very nice return, worth checking out..
current target price is $27 based on the one product they are going to apply for approval of.
To see $100, all of those other ones in development/trials are going to have to 'show' something during their PH 2s..
Disclaimer: nice frigging move off the $4/sh lows... Been wondering WHAT someone knows and I suspect its got to do with
the pending NDA submission which is expected to take place sometime before the 3rd qtr..
Don't own any because I am still fully committed to another one about to commence its sales post its FDA approval...
And its something that should have happened at least 2 years earlier but thats been delayed and ruined my plans of rotating some
out of that one into ATNM..
agree with you... What was the purpose for the question when it would be very easy to look thru their PR to see if one had been
issued.
But again, ya can't get one till an NDA review has commenced as far as I am aware of.
But on a side note, nice move developing in the share price and have to wonder if its in anticipation of the NDA submission pending..
disclaimer: hadn't bought any back yet because of a delay in things moving forward in CRMD (has been approved, expected to commence sales in April, but the market has not run it up as expected in anticipation of this occurring as it would normally be expected to happen: share price $3.33, 1st target price is $14-15 and I own shares. So yeah, its slow move has cost me a chance to flip some of those shares for ATNM which I had fully intended to do.. Dang nab it all)
So did investors get a 'gift'?
Just heard about CKPT after the CRL came out. First comment is, resolution of the CRL could take longer than folks expect, just went thru it with CRMD and they got 2 CRLS due to the manufacturers QA issues (4 frigging years for the fda to agree to the 'fixes' and all the while the manufacturers were ALLOWED to continue operations under the fda umbrella, someone explain that one)
Anyways, so looking into CKPT, like the low share count, don't like the low cash on hand cause can only read it to mean, thanks to the delay, they will likely need to conduct a cash raising operation (ATM or flat out secondary). CRMD had to do this and it really cut their target price down.
So, just thought I would check in, see what folks are saying, and quite frankly, a bit surprised given its a cancer related treatment, given how the market is pricing so many bios as if they are selling gold, that CKPT was where it was on the share price..
But going to be studying their trial analysis, how good they see it working. And really tired of the fda holding up drug approvals for drugs that CAN/WOULD help save lives vs delaying the approval especially if it worked. Now I wouldn't be as 'upset' at the fda if as in this case, they tell the manufacturer, since you are bad enough for us not to approve a potential life saving drug, your operations are totally suspended.
Otherwise, to me, the fda has its priorities screwed up.. when it allows operations to continue.. but puts a life saving drug into limbo land.. again, CRMD has something going for it, hell of a lot better than the current standard of care, but was delayed 4 frigging years over QA issues.
Good luck
Kind of nice to see it pulling back from its highs. At this stage, hopefully folks took the gains it gave with a disclaimer that I did sell out way too soon as I didn't see the run getting as crazy as it did.
But that said, liking the pullback. Chart is suggesting more downside is 'possible'. Given that they won't complete the study until in 2024? IF this market continues to 'sour', expecting it to get 'cheaper'..
Disclaimer: like it, but own none at the moment. Just checking into see if anyone had anything to say..
a lot of 'baby' bios are getting hacked up. CRMD for example just rec'd FDA approval of a compound that WILL become the standard of care because of its effectiveness. And despite the news, since the 'launch' isn't till (later?) in the 1st qtr 2024, its gone 'no where' on the news.
ATNM has gotten clocked, but what the heck, given a target price of $20+ (if they would stop selling frigging shares), its a 'gift' at these prices. But like CRMD, its going to have to EXECUTE (get approved and get sales going).
Got 1 other that has very good potential, but again, folks just don't seem to be interested in something that isn't 'doing'
I was just browsing thru their website, going over their Nov presentation. Was looking for an update on the BLA filing, see someone posted its now into the 1H 2024. Was going to start accumulating, but a look at the chart is indicating $4 may not hold now. So going to continue to be patient. Cause I suspect given the early stages for the rest of their effort (and years to an endpoint), the only thing that might turn this around would be news of the filing. And with that pushed back? LIke CRMD, the market is not being kind to baby bios. Course the other thing is, when the market turns from 'no price is too high' to lets get 'real''? Whats a 'fair value' takes on a whole different perspective. (example: Sava back when it was completing a PH 2 hit over $120/sh look at where its at now..and I would argue its still overvalued given what they have PROVEN)
Disclaimer: still being patient to buy back in.. And getting it down here just increases the potential reward if they can get approved)
But the opportunity to be taken advantage of.
Had another one CRMD get I suspect 'shorted' down heavily in the run up to its pending decision date (Nov 15th. Now at $3.3-3.4 range, target is still $14-15)..
Been watching ATNM and kind of wondering if it would get a similar share price hit.
And as far as I know, its still on track for an NDA submission before the end of the year?? So going to take advantage of this and start accumulating a position. And see it still has a target price of $27 making this price level or less, one heck of a buy given that their development 'appears/sounds' successful/approvable.
Disclaimer: own none at the moment, but going to after this takedown.
I am starting to wonder if the 'length' of time to get something approved is relational to whether its a 'baby bio' vs one of the big pharma - fda 'revolving' door companies up for approval.
And yeah, the covid scam/hoax demonstrated how things 'really' work when 'something' is 'desired' didn't it.
agree. Just that I am 'all in' on CRMD and its pending Nov 15th date with the FDA.. Looking for $12 to $15 on that one for starters. Damn delays in its approval have cost me 'opportunities' on another one as I have had to 'wait'... far longer than expected over 2 years ago.. And now a bargain on ATNM
Be nice to roll some of that one into some shares sub $8 on this one..
Been a while, but have been monitoring the share price trend. Also tracking the FLOAT, hope they can keep it sub 30 Mil shares (26 Mil) so that the darn 'target price' doesn't get hit like it has for one I am heavily in at the moment (delays in their approval timeline has forced ATM dilution).
And know this won't be a likeable comment, but if it can hold sub $8 into the end of the year?? With a target price of around $25-30?? Be a happy buyer for the run into their approval decision (question is, are they still on track for an NDA submission late this year??)
disclaimer: currently own none, but am bullish especially as the price has slid lower
Had bought a few thousand shares @ $1.35 and lower range.. Sold them on this pop at around $1.90. Long ways to the 1st qtr 2024 when this trial ends..
Hopefully the share price retries the $1.50 or below level.. Would like to buy another round..
Street target price: Avg based on yahoos finance page is $31/sh...
Something to track although they say they have a lot of cash on hand (they should they doubled up the damn share count to 25 Million) is the 'share count' which as of the end of the 1st qtr 2023 is around 25 Million..
So from a timeline standpoint, end of this year for an NDA submission.. add 9 months to that..
If I had shares right now, I would be selling the covered calls for what I could get, at the $10 level. Just don't see a reason coming in the near future to jeopardize $10/sh..
disclaimer: still don't have any, loaded with CRMD which just got their timeline clarified, sitting at $5/sh, target price $15 on 41 Million shares outstanding. And if they get the additional sector (oncology) we know they will be asking approval for, well that puts the target price north around $25+.. Just going to take till the end of the year for an FDA decision from the looks of it.
Been watching the share price and have to say, its gotten 'attractive' again at sub $10/sh..
See that they intend to file their NDA later this year, so given the time after that for a decision (around 9 months after the NDA is accepted),
Guess I will be looking to take another 'round' with this one..
and agree, unless the fed death agency screws around with them, the data indicates is should be approvable.
disclaimer: own none, but will be looking to accumulate.. Good luck.. at least there is a timeline now..
ATNM PR makes me think I missed something. For in the PR, they discuss their 'financial/expansion' activity in the EU..
and say the market share there MIGHT be bigger than what they have in the US.
IF this is accurate, my target price looks like its going to be 'way' low cause I didn't 'see' this coming.
And I hadn't heard anything about the EU mentioned before in terms of a revenue stream.
Be interesting to see what the analysts do with this info, what target price they start to 'update to' now.
Disclaimer: I own none, but one of my kids held onto their shares and is enjoying the run (we were selling calls for some time, so the cost basis is sub $10/sh)
nice run in progress. My son kept his shares so he is now up some on them.
Still have a $20/sh target price due to the higher share count. Hopefully for those holding,
when they start to talk about marketing, they get better numbers in terms of reimbursement rates.
Good luck to those holding. Note, I am still following their other programs in progress, but they have
a ways to go..
Note, son will likely take what it gives and move the gains into shares of CRMD if that still hasn't gotten
the clearance from the fda to move towards its own approval.
Again, good luck
On this one, I don't trust the change in a biomarker to be a hard confirmation that it really is having a positive affect.
Why I didn't like that they tried to say, hey we can prove we can change a biomarker, therefore, we can claim it IS helping folks. (before they discarded that effort way back when)
so what have you seen in terms of data to support your statements on sava?
For my understanding of the PH 2 was that what was reported in terms of 'response' was NOT part of the official data gathering the PH 2 collected. But instead was reportedly 'observations'.
Thats the part I challenged folks over. Did the PH 2 actually 'measure/intentionally' collect this data in a manner that was trustworthy/planned/intentional or just 'anecdotal'.
Thanks.
Has cassava actually confirmed their drug WORKS to help folks?
Just asking cause I have followed it for quite a while and am not convinced by anything they have said to date. And in challenges I have put up to the 'believers' on another site, I get 'crickets' in terms of the 'proof' they believe in.
And I have traded cassava a few times, but after they flipped that PH 2 data from 'this is not good' to 'good' without a good explanation? I have been overly cautious to believe they have confirmed anything until the PH 3 results are out.
and even on this one, I was cautious and didn't own shares up until the last minute before the Ph 3 results were talked about. And I still don't own a lot of shares just cause its ALZ related and am not clear on what they said.
You again miss the point. I just checked 10 random companies and they all provide links to their SEC reports. This includes a tiny biotech with only 3 employees. Why is AVXL different? Perhaps incompetence in their IR department?
If YOU are capable, all you have to do is go to EDGAR for their SEC reports. This is perfectly ACCEPTABLE, although possibly a 'challenge' for some to do.
https://www.anavex.com/sharedata